Perrigo Company PLC marks another first in its transition to being entirely consumer health-focused with approval in the US of proton pump inhibitor omeprazole magnesium 20-mg delayed-released in mini-capsule format.
The capsule is 70% smaller than tablets of omeprazole currently available in the Prilosec OTC brand marketed by Procter & Gamble under license from innovator AstraZeneca PLC and...